Century Therapeutics, Inc.IPSCNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank50
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-1.78%
↑ 100% vs avg
Percentile
P50
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-1349.71%
Historical baseline
PeriodValueYoY Change
TTM-1.78%+99.9%
2024-1691.79%+68.8%
2023-5423.18%-132.6%
2022-2331.24%-
20210.00%-
20200.00%-
20190.00%-